Zai Lab Ltd(ZLAB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ZLAB Zai Lab Ltd

Market Closed 11-06 16:00:00 EST

25.48

+2.88

+12.74%

盘后25.10

-0.38-1.49%

19:58 EST

High25.99	Low23.35	Vol1.89M
Open23.55	D1 Closing22.60	Amplitude11.68%
Mkt Cap2.86B	Tradable Cap2.47B	Total Shares112.35M
T/O47.46M	T/O Rate1.95%	Tradable Shares97.11M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ZLAB","market":"US","secType":"STK","nameCN":"Zai Lab Ltd","latestPrice":25.48,"timestamp":1793998800000,"preClose":22.6,"halted":0,"volume":1894963,"hourTrading":{"tag":"盘后","latestPrice":25.1,"preClose":25.48,"latestTime":"19:58 EST","volume":4982,"amount":125893.1525,"timestamp":1794013081114,"change":-0.38,"changeRate":-0.014914,"amplitude":0.038462},"delay":0,"changeRate":0.127433628318584,"floatShares":97110400,"shares":112353700,"eps":-1.702952,"marketStatus":"Market Closed","change":2.88,"latestTime":"11-06 16:00:00 EST","open":23.55,"high":25.99,"low":23.35,"amount":47464748.979550004,"amplitude":0.116814,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.702952,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1794214800000},"marketStatusCode":7,"adr":1,"adrRate":10,"listingDate":1505880000000,"exchange":"NASDAQ","adjPreClose":22.6,"preHourTrading":{"tag":"盘前","latestPrice":23.2785,"preClose":22.6,"latestTime":"08:48 EST","volume":11259,"amount":262451.56841999997,"timestamp":1793972917757,"change":0.6785,"changeRate":0.030022,"amplitude":0.05},"postHourTrading":{"tag":"盘后","latestPrice":25.1,"preClose":25.48,"latestTime":"19:58 EST","volume":4982,"amount":125893.1525,"timestamp":1794013081114,"change":-0.38,"changeRate":-0.014914,"amplitude":0.038462},"volumeRatio":1.6864388801278734,"impliedVol":0.9557,"impliedVolPercentile":0.9323},"requestUrl":"/m/hq/s/ZLAB","defaultTab":"news","newsList":[{"id":"2681150698","title":"Zai Lab (ZLAB) Advances Zoci Toward Phase 3 In Extrapulmonary Neuroendocrine Carcinomas","url":"https://stock-news.laohu8.com/highlight/detail?id=2681150698","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681150698?lang=en_us&edition=fundamental","pubTime":"2026-11-07 11:28","pubTimestamp":1794022132,"startTime":"0","endTime":"0","summary":"SSasha JovanovicNovember 7, 2026","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zlab/zai-lab/news/zai-lab-zlab-advances-zoci-toward-phase-3-in-extrapulmonary","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zlab/zai-lab/news/zai-lab-zlab-advances-zoci-toward-phase-3-in-extrapulmonary","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4531","ZLAB","BK4585","BK4588","BK4526","BK4139","LU2488822045.USD","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681815805","title":"China Cranks Out New Drugs. How to Play It.","url":"https://stock-news.laohu8.com/highlight/detail?id=2681815805","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681815805?lang=en_us&edition=fundamental","pubTime":"2026-11-07 10:31","pubTimestamp":1794018660,"startTime":"0","endTime":"0","summary":"Merck won plaudits at the European Society for Medical Oncology for the first pivotal trial of sac-TMT, which it licensed from Chengdu-based Sichuan-Kelun Pharmaceutical and whose revenue Merck hopes ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ99366536.SGD","SG9999001176.SGD","LU1037948897.HKD","LU2125154778.USD","LU1868837300.USD","SG9999014559.SGD","BK4585","LU0786609619.USD","BK4007","LU1023059063.AUD","LU0594300419.USD","SG9999002232.USD","BK4534","LU1145028129.USD","LU1003077747.HKD","LU2552382058.USD","LU0061475181.USD","LU2242644610.SGD","LU2237443465.HKD","SG9999014567.USD","LU0124676726.USD","LU1066051498.USD","LU2087625088.SGD","SG9999001176.USD","LU0203347892.USD","IE00BLSP4239.USD","LU2237443978.SGD","LU1781817850.SGD","LU1988902786.USD","LU0070302665.USD","LLYZ","BK0239","LLY","IE00BK4W5M84.HKD","LU0320765059.SGD","LU2023250504.SGD","LU0432979614.USD","LU0006306889.USD","LU1236620750.USD","LU0306806265.USD","LU1066053197.SGD","LU2471134796.USD","LU0502904849.HKD","LU0210536198.USD","LU1894683264.USD","LU2111349929.HKD","IE00B3T34201.USD","TRUH","LU2125909247.SGD","LU2089283258.USD","LU2491049909.HKD","LU1829250122.USD","AZNH","LU2596442595.SGD","IE00BLSP4452.SGD","LU0417516738.SGD","LU0238689110.USD","LU0348783233.USD","CURE","LU2417539215.USD","LU1064131003.USD","LU0069063385.USD","MEDX","SG9999015945.SGD","LU0244354667.USD","LU1066051225.USD","LU1868836914.USD","BK4550","LU0122379950.USD","LU0072461881.USD","LU0158827781.USD","IE0004445015.USD","LU2264538146.SGD","LU0203202063.USD","LU0057025933.USD","GB00BDT5M118.USD","LU2097828557.USD","LU1116320737.USD","LU1255011170.USD","LU0823416689.USD","SG9999014880.SGD","LU0133085943.USD","LU1061106388.HKD","ZLAB","LU0130517989.USD","LU2089984988.USD","LU2237443895.HKD","LU0326950275.SGD","LU0882574055.USD","LU2236285917.USD","LU0965509283.SGD","LU0889565916.HKD","LU2168564495.EUR","06963","LU0174119429.USD","LU0471298694.HKD","BK4533","LLYX","LU0965509101.SGD","LU2357627491.SGD","01276","LU1868837136.USD","SMMT","LU1917777945.USD","LU0634319403.HKD","LU0661504455.SGD","LU0965509010.AUD","LU0943347566.SGD","LU2778985437.USD","LU1699723380.USD","TMED","LU2108987350.USD","LU2750360641.GBP","LU1868836757.USD","LU1974910355.USD","LU0097036916.USD","IE00BKDWB100.SGD","LU0353189763.USD","LU2324357040.USD","LU1894683348.USD","BK1184","LU0225283273.USD","BK4599","LU0942090050.USD","LU1868836591.USD","LU0787776722.HKD","LU0348784397.USD","LU0672654240.SGD","LU2471134523.USD","LU1551013342.USD","LU2106854487.HKD","LU1093756325.SGD","LU2125154935.USD","LU2471134879.HKD","SGXZ31699556.SGD","LU0348766576.USD","LU1623119135.USD","LU2361044949.HKD","LU2168564065.EUR","LU0109391861.USD","LU2468319806.SGD","LU2023250843.SGD","LU1934455194.USD","LU0289739343.SGD","IE00B1XK9C88.USD","LU1804176565.USD","LU1069344957.HKD","WDNA","GSK","LU0348827113.USD","LU0265550359.USD","LU2357305700.SGD","LU0106261372.USD","BK0028","LU2746668974.SGD","LU0345770993.USD","LU2125909593.SGD","MRK","SG9999014542.SGD","LU1941712264.USD","LU2271345857.HKD","LU0114720955.EUR","GSKH","LU0477156953.USD","LU2756315664.SGD","LU2495084118.USD","SG9999014914.USD","LU2433249047.HKD","SGXZ81514606.USD","LU0162691827.USD","IE00BK4W5L77.USD","LU0708994859.HKD","LU2602419157.SGD","CANC","LU0348825331.USD","LU0648001328.SGD","LU1116320901.HKD","LU2756315318.SGD","LU0385154629.USD","LU1267930730.SGD","LU2289578879.USD","BK1583","LU2023251221.USD","LU0316494557.USD","SG9999015986.USD","LU1629891620.HKD","LU0289739699.SGD","IE00B19Z3B42.SGD","LU2023250330.USD","BK0196","LU0203201768.USD","IE00B7KXQ091.USD","LU1941712348.USD","BK4592","AZN","LU0553294199.USD","09688","LU2491050154.USD","LU2097828805.USD","RXL","LU0170899867.USD","LU0820562030.AUD","IE0009355771.USD","SG9999018857.SGD","LU2097828474.EUR","IE0005OL40V9.USD","LU1093756168.USD","LU0463099449.HKD","LU2063271972.USD","LU0354030438.USD","LU0650527681.SGD","LU0683600562.USD","LU1983299246.USD","IE0004445239.USD","LU0594300179.USD","LU0348735423.USD","BK4588","IE00BJJMRX11.SGD","IE00BJT1NW94.SGD","LU1064130708.USD","LU2265009873.SGD","LU2552382132.HKD","LU0256863811.USD","LU0417516902.SGD","LU1989771016.USD","LU0345770308.USD","LU2168564149.EUR","LU0225771236.USD","LU2488822045.USD","LU1551013425.SGD","BK0060","PJP","LU1236620834.HKD","LU0058720904.USD","LU0471298777.SGD","LU1057294990.SGD","LU1655091616.SGD","LU0208291251.USD","LU2168563687.JPY","SG9999014906.USD","LU0011850046.USD","SG9999002224.SGD","IE00BJJMRZ35.SGD","LU1366192091.USD","IE0002270589.USD","IXJ","LU1997245177.USD","LU2746668461.USD","LU0417516571.SGD","LU2237443622.USD","LU0225284248.USD","LU2237438978.USD","LU0158827948.USD","LU2328871848.SGD","LU2471134952.CNY","09926","LU0738911758.USD","LU2237443549.SGD","LU2213496289.HKD","LU2399975544.HKD","BK0183","IHE","LU0823434583.USD","LU1989772923.USD","SG9999011175.SGD","LU0861579265.USD","LU1032466523.USD","LLII","01801","JDOC","LU0130102774.USD","BK4139","LU2112291526.USD","BK4526","FTXH","IE00BSNM7G36.USD","LU0348767384.USD","IE00BFSS8Q28.SGD","LU0511384066.AUD","LU2211815571.USD","SGXZ51526630.SGD","LU0472753341.HKD","LU0289961442.SGD","LU0607220059.USD","LU1069347547.HKD","LU2552382215.SGD","IE00B2B36J28.USD","LU2476274720.SGD","BK4532","BK4581","LU1989772840.SGD","LU0198837287.USD","LU0882574139.USD","LU2462591350.SGD","LU2476274308.USD","LU2097828631.EUR","AGNG","LU0545039389.USD","LU0079474960.USD","LU1580142542.USD","LU0320765489.SGD","LU0689472784.USD","LU1934455277.USD","IE00BWXC8680.SGD","BK4548","LU1979441026.SGD","BK1161","LU2168564222.USD","IYH","SG9999015952.SGD","LU2580892789.USD","LU1997244956.HKD","IE00B4R5TH58.HKD","SG9999017495.SGD","LU2491050071.SGD","LU1188198961.HKD","LU1201861249.SGD","LU0964807845.USD","LU1548497426.USD","GSK.UK","LU0980610538.SGD","LU2211817866.USD","LU0321505439.SGD","LU0265550946.USD","LU0211331839.USD","HRTS","LU0689626769.HKD","LU1430594728.SGD","BK4516","LU2361045086.USD","LU0965508806.USD","LU1934455863.HKD","LU0949170772.SGD","PAWZ","IE00BPRC5H50.USD","LU1969619763.USD","MEDI","LU2360106947.USD","LU1280957306.USD","LU2896262040.SGD","LU0354030511.USD","IE00BFTCPJ56.SGD","LU0985481810.HKD","LU0353189680.USD","LU1929549753.HKD","LU1571399168.USD","LU0098860793.USD","SG9999014575.USD","LU2089284900.SGD","SG9999001440.SGD","IE000M9KFDE8.USD","LU1146622755.USD","ELIL","LU0256863902.USD","LU0306807586.USD","IE00BJJMRY28.SGD","LU0128525929.USD","XLV","LU1720050803.USD","LU1035773651.USD","IE00BFSS7M15.SGD","BK1574","LU0466842654.USD","LU1585245621.USD","LU0640476718.USD","LU2461242641.AUD","LU1037948541.HKD","LU1291159041.SGD","LU0321505868.SGD","LU2462157665.USD","LU1064131342.USD","LU0868494617.USD","LU0823434740.USD","IE00BJLML261.HKD","ILDR","LU1961090484.USD","SG9999015341.SGD","BK4568","600276","LU1035775433.USD","IE00B4JS1V06.HKD","THNR","IE0002141913.USD","LU1267930573.SGD","LU2148510915.USD","BK4531","IE00BN8TJ469.HKD","LU1323610961.USD","LU0417517546.SGD","LU1794554557.SGD","OZEM","IE00B543WZ88.USD","LU1883839398.USD","BK0012","LU0203345920.USD","LU1923622614.USD","LU0149534421.HKD","LU0320765646.SGD","SG9999013999.USD","GDOC","LU0820561909.HKD","LU1127390331.HKD","LU0234572021.USD","VHT","LU0985320562.USD","LU0310800379.SGD","MHIP","IE00BKPKM429.USD","LU1232071149.USD","LU0456855351.SGD","IE0001KFT4U8.USD","LU2456880835.USD","LU0540923850.HKD","LU0605514214.HKD","HK0000165453.HKD","SG9999018865.SGD","LU0561508036.HKD","LU0820561818.USD","LU1820825898.SGD","LU0320765992.SGD","LU2097828714.EUR","BMED","LU1691799644.USD","LU1328615791.USD","LU2360032135.SGD","FHLC","BK0188","PFE","LU1712237335.SGD","LU1066051811.HKD","LU1720051017.SGD","PPH","LU0109394709.USD","LU1153585028.USD","SG9999015978.USD","LU0868494708.USD","LU0029864427.USD","LU1720051108.HKD","IE00B5MMRT66.SGD","LU2750360997.AUD","SG9999014898.SGD","LU1997245094.SGD","IE00B1BXHZ80.USD","SGXZ57979304.SGD","SG9999003800.SGD","IE00BN29S564.USD","LU0405327148.USD","LU0708995401.HKD","KURE","LU0455707207.USD","LU2361044865.SGD","LU1831875114.USD","LU0405327494.USD","IE00BBT3K403.USD","ELIS","IE00B775H168.HKD","LU0096364046.USD","BK1589","BK4559","LU0266013472.USD","LU0859254822.USD","SG9999015358.SGD","LU0323591593.USD","LU2237443382.USD","LU2580892862.HKD","LU1162221912.USD","LU2028103732.USD","LU1814569148.SGD","LU0094547139.USD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681182896","title":"Zai Lab Q3 Performance Meets Expectations With Pivotal 2027 Ahead, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2681182896","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681182896?lang=en_us&edition=fundamental","pubTime":"2026-11-07 01:42","pubTimestamp":1793986944,"startTime":"0","endTime":"0","summary":"Zai Lab's  Q3 results were broadly in line with expectations, with progress across its global drug pipeline, UBS said in a note emailed Friday.The analysts said 2027 is expected to be a pivotal year, with the company planning to release key data from its second-line small cell lung cancer trial and potentially seek regulatory approval.The company also plans to file for approval for its neuroendocrine carcinoma treatment, targeting an area with no currently approved therapies, the analysts added.Zai Lab's China business has remained \"stable\" in recent quarters, particularly for Vyvgart, the analysts said, adding that management expects the China business to return to growth in 2027.\"Overall, we think multiple meaningful catalysts for the stock in 2027 and progress across the global pipeline and China business,\" the analysts added.UBS kept its buy rating on the stock with a $35 per share price target. Shares of the company were up nearly 11% in the session.Price: 25.05, Change: +2.45, Pe","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4531","BK4585","BK4526","BK4588","BK4548","LU2488822045.USD","BK4139","ZLAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681838678","title":"Zai Lab (ZLAB) Stock Looks Above Fair Value On Current Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2681838678","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681838678?lang=en_us&edition=fundamental","pubTime":"2026-11-06 10:36","pubTimestamp":1793932614,"startTime":"0","endTime":"0","summary":"BBailey PembertonNovember 6, 2026","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zlab/zai-lab/news/zai-lab-zlab-stock-looks-above-fair-value-on-current-sales","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zlab/zai-lab/news/zai-lab-zlab-stock-looks-above-fair-value-on-current-sales","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ZLAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681000540","title":"Zai Lab Ltd Reports Results for the Quarter Ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2681000540","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681000540?lang=en_us&edition=fundamental","pubTime":"2026-11-06 02:16","pubTimestamp":1793902584,"startTime":"0","endTime":"0","summary":"Zai Lab Ltd reports results for the quarter ended September 30 - Earnings SummaryZai Lab LtdZLAB.OQreported a quarterly adjusted loss of 40 cents per share for the quarter ended September 30, lower th","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nL5N46M2UM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4526","BK4585","LU2488822045.USD","BK1161","BK1588","BK4588","BK4139","BK4531","09688","BK4548","BK1574","ZLAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681074904","title":"Zai Lab Q3 Loss Widens, Revenue Declines","url":"https://stock-news.laohu8.com/highlight/detail?id=2681074904","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681074904?lang=en_us&edition=fundamental","pubTime":"2026-11-05 22:29","pubTimestamp":1793888944,"startTime":"0","endTime":"0","summary":"Zai Lab  reported a Q3 net loss Thursday of $0.41 per American depositary share, widening from a loss of $0.33 a year earlier.Analysts polled by FactSet expected a loss of $0.58.Total revenue for the quarter ended Sept. 30 was $108.2 million, down from $116.1 million a year earlier.Analysts expected $107.9 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4531","BK4139","BK4548","LU2488822045.USD","ZLAB","BK4526","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681301071","title":"Zai Lab presents updated clinical data on zocilurtatug pelitecan","url":"https://stock-news.laohu8.com/highlight/detail?id=2681301071","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681301071?lang=en_us&edition=fundamental","pubTime":"2026-11-05 22:17","pubTimestamp":1793888243,"startTime":"0","endTime":"0","summary":"Zai Lab (ZLAB) announced that updated data from a Phase 1b/2 trial of zocilurtatug pelitecan, a DLL3-targeting antibody-drug conjugate, will be sha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zai-lab-presents-updated-clinical-data-on-zocilurtatug-pelitecan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zai-lab-presents-updated-clinical-data-on-zocilurtatug-pelitecan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4531","BK4139","BK4526","BK4588","BK4548","ZLAB","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171136245","title":"Zai Lab Q3 2026 Revenue Reaches $108.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1171136245","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171136245?lang=en_us&edition=fundamental","pubTime":"2026-11-05 20:21","pubTimestamp":1793881260,"startTime":"0","endTime":"0","summary":"Zai Lab (09688) has announced its financial results for the third quarter of 2026, reporting total revenue of $108.2 million, compared to $116.1 million in the same period of 2025.Net product revenue...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK4526","BK4585","BK4588","09688","ZLAB","BK4139","BK1161","BK4531","LU2488822045.USD","BK4548","BK1588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681197029","title":"Zai Lab Q3 EPS $(0.04) Beats $(0.07) Estimate, Sales $108.208M Beat $105.825M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2681197029","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681197029?lang=en_us&edition=fundamental","pubTime":"2026-11-05 19:31","pubTimestamp":1793878288,"startTime":"0","endTime":"0","summary":"Zai Lab (NASDAQ:ZLAB) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.07) by 33.33 percent. This is a 33.33 percent decrease over losses of $(0.03) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/11/62908898/zai-lab-q3-eps-0-04-beats-0-07-estimate-sales-108-208m-beat-105-825m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4526","BK4139","BK4531","BK4588","LU2488822045.USD","ZLAB","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681106029","title":"Press Release: Zai Lab Announces Third Quarter 2026 Financial Results and Recent Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2681106029","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681106029?lang=en_us&edition=fundamental","pubTime":"2026-11-05 19:30","pubTimestamp":1793878200,"startTime":"0","endTime":"0","summary":"ESMO: 81.8% confirmed ORR, an estimated 81.9% six-month PFS rate and 9.1%. Grade >=3 zoci-related AEs; advancing toward a global Phase 3 study in 1L. --  Registrational global Phase 3 DLLEVATE study evaluating zoci in 2L+. SCLC is ongoing, with a potential interim analysis in the second half of. 2027, followed by a subsequent U.S. accelerated approval submission. --  Completed enrollment in zoci's potentially registrational 2L epNECs. expansion cohort, with data expected in the first half of 2027, followed. --  ZL-1503, a long-acting IL-13/IL-31R<ALPHA> bispecific antibody, is. advancing toward key clinical milestones including initial first-in-human. data at 2026 ACAAI and atopic dermatitis patient data expected in the. --  Total revenues of $108.2 million in the third quarter of 2026 with 2%. sequential net product revenue growth; positioned for a return to","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZLAB","BK7016","BK4526","BK4211","BK4531","BK4588","ORR.AU","BK4548","BK7095","BK4139","ADS.AU","BK4585","LU2488822045.USD","ORR","BK4195","PFS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110854726","title":"Earning Preview: Zai Lab Ltd Q3 revenue expected to decrease by 24.22%, institutional views are mixed but lean cautious","url":"https://stock-news.laohu8.com/highlight/detail?id=1110854726","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110854726?lang=en_us&edition=fundamental","pubTime":"2026-10-29 22:16","pubTimestamp":1793283362,"startTime":"0","endTime":"0","summary":"Abstract Zai Lab Ltd will report third-quarter 2026 results on November 5, 2026 Pre-MKt; this preview outlines consensus expectations for revenue, margin, and EPS alongside segment dynamics and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Earning Preview: Zai Lab Ltd Q3 revenue expected to decrease by 24.22%, institutional views are mixed but lean cautious","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZLAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123100094","title":"Zai Lab's Zoci Earns Strong Backing as a Potential Backbone Therapy, Continues to Expand Its Future Value Horizon","url":"https://stock-news.laohu8.com/highlight/detail?id=1123100094","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123100094?lang=en_us&edition=fundamental","pubTime":"2026-10-27 21:54","pubTimestamp":1793109265,"startTime":"0","endTime":"0","summary":"Recently, the 2026 European Society for Medical Oncology (ESMO) congress was held in Madrid, Spain, drawing widespread attention from the international academic community, while global...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4526","BK4531","BK4139","09688","BK4548","BK4588","BK1161","ZLAB","LU2488822045.USD","BK1588","BK1574","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678419456","title":"Zai Lab (ZLAB) Receives a Buy from Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2678419456","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678419456?lang=en_us&edition=fundamental","pubTime":"2026-10-26 22:39","pubTimestamp":1793025594,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Li Watsek from Cantor Fitzgerald maintained a Buy rating on Zai Lab, with a price target of $37.00. According to Ti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/zai-lab-zlab-receives-a-buy-from-cantor-fitzgerald-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/zai-lab-zlab-receives-a-buy-from-cantor-fitzgerald-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4526","BK4139","BK4588","LU2488822045.USD","BK4585","BK4531","BK4548","ZLAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678660531","title":"Zai Lab (ZLAB) Climbed, So What Is Driving Attention Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2678660531","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678660531?lang=en_us&edition=fundamental","pubTime":"2026-10-26 17:33","pubTimestamp":1793007222,"startTime":"0","endTime":"0","summary":"Zai Lab (ZLAB) is back in focus after early Phase 1b data for its lung cancer candidate zocilurtatug pelitecan, or zoci, presented at ESMO 2026, showed high response rates and a tolerable safety profile.\nThe zoci update arrived during a sharp move in Zai Lab’s shares. The latest 1-day share price return of 9.03% added to a 90-day share price return of 29.05% and a year-to-date share price gain of 38.66%. This came even though the 1-year total shareholder return declined 8.77% and the 5-year...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zlab/zai-lab/news/zai-lab-zlab-climbed-so-what-is-driving-attention-now","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zlab/zai-lab/news/zai-lab-zlab-climbed-so-what-is-driving-attention-now","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2488822045.USD","ZLAB","BK4139","BK4531","BK4585","BK4526","BK4588","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106000455","title":"Zai Lab Shares Surge Over 7% Intraday as Zoci Plus Atezolizumab First-Line ES-SCLC Data Debuts at ESMO","url":"https://stock-news.laohu8.com/highlight/detail?id=1106000455","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106000455?lang=en_us&edition=fundamental","pubTime":"2026-10-26 09:50","pubTimestamp":1792979433,"startTime":"0","endTime":"0","summary":"Zai Lab Ltd (SEHK: 09688) shares climbed more than 7% intraday, and as of press time the stock was up 5.91% at HK$18.83, with turnover of HK$32.42179 million.On October 23, Zai Lab Ltd (SEHK: 09688)...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK4139","BK4588","LU2488822045.USD","BK4548","ZLAB","BK1161","BK4526","BK1588","09688","BK4531","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169749685","title":"Zai Lab Stock Rises Over 2% as Early-Stage Data for Investigational ADC Zoci Shows Promise","url":"https://stock-news.laohu8.com/highlight/detail?id=1169749685","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169749685?lang=en_us&edition=fundamental","pubTime":"2026-10-23 23:42","pubTimestamp":1792770135,"startTime":"0","endTime":"0","summary":"On Friday, Zai Lab Ltd (ZLAB.US) saw its shares climb nearly 10% at the market open before settling to a gain of more than 2%, trading at $22.62.On October 23, Zai Lab Ltd released global Phase Ib...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1588","BK4548","BK4139","BK1161","BK4526","BK4585","BK4588","LU2488822045.USD","09688","BK1574","BK4531","ZLAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677739609","title":"Asian Equities Traded in the US as American Depositary Receipts Decline in Friday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2677739609","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677739609?lang=en_us&edition=fundamental","pubTime":"2026-10-23 22:40","pubTimestamp":1792766437,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were lower Friday morning, down 0.84% to 2,823.84 on the S&P Asia 50 ADR Index. At that level, the index was over 3% lower for the week.From North Asia, the gainers were led by biopharmaceutical company Zai Lab  and internet and data center services provider VNET Group , which advanced 7.1% and 2.1% respectively. They were followed by fintech firm Jiayin Group , which rose 1.2%.The decliners from North Asia were led by commercial real estate and digital security firm Eason Technology  and LexinFintech , which dropped 16% and 2.9% respectively. They were followed by lenders Mitsubishi UFJ Financial Group  and Shinhan Financial Group , which were down 2.3% and 1.7% respectively.From South Asia, the lone gainer was pharmaceutical company Dr. Reddy's Laboratories , which increased 1.6%.The decliners from South Asia were led by IT firm Infosys  and telecommunications operator PLDT , which lost 5.8% and 2.5% respectively. They w","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4107","LX","RDY","SGXZ90724238.SGD","VNET","BK4533","BK4548","SHG","LU0630378429.USD","LU0049112450.USD","PHI","EDOG","SHG.AU","RDY.AU","DXF","LU0791591158.USD","LU0307460401.USD","BK4526","LU1868837565.USD","LU2177674079.SGD","LU1105468828.SGD","JFIN","LU2488822045.USD","LU0348814723.USD","LU0918141887.USD","BK4566","IBN","LU0348744763.USD","LU0828237940.HKD","INFY","BK7016","LU0072462343.USD","AFG","IE00BYTNYM70.SGD","LU0528227936.USD","ZLAB","BK4523","BK4007","BK4164","HDB","LU0918141705.HKD","LU0531971678.HKD","BK4579","LU0287143357.SGD","LU2663582299.SGD","MUFG","LU0862451753.SGD","LU0791590937.USD","LU1267930656.SGD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677929677","title":"Zai Lab Shares Rise on Positive Phase 1 Trial Data for Lung Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2677929677","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677929677?lang=en_us&edition=fundamental","pubTime":"2026-10-23 19:25","pubTimestamp":1792754700,"startTime":"0","endTime":"0","summary":"Zai Lab shares rose in premarket trading Friday after the company said that it reported positive data from its phase 1 trial evaluating its small cell lung cancer treatment.Shares rose 7.3% ahead of the morning bell to $23.65.The biopharmaceutical company said Friday that its experimental drug, zocilurtatug pelitecan, showed high tumor response rates and a favorable safety profile. This was when combined with an immunotherapy treatment in patients receiving initial care for advanced small cell lung cancer.\"The high confirmed response rate, encouraging durability, and well-tolerated safety profile we are seeing with a standard chemotherapy-free regimen are particularly compelling,\" said President and Head of Global Research and Development Rafael Amado.The company said that it is preparing to begin a global phase 3 trial of the drug as well as an immuno-oncology regimen to explore other potential combinations.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2488822045.USD","BK4588","ZLAB","BK4548","BK4526","BK4531","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677949118","title":"Zai Lab to Privately Place $250 Million in ADRs to Fund Drug Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2677949118","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677949118?lang=en_us&edition=fundamental","pubTime":"2026-10-23 15:55","pubTimestamp":1792742151,"startTime":"0","endTime":"0","summary":"Zai Lab  agreed to privately place $250 million of American Depositary Shares with certain investors, to fund ongoing development of its drug zocilurtatug pelitecan, used to treat neuroendocrine cancers, the company said Friday.The company placed 11.34 million new ADS shares at a price of $22.04 each, with each share representing 10 ordinary shares of the company.The company's private investment in public equity, or PIPE financing, is expected to close on or about Oct. 27.The financing is led by investment shop TCGX, with participation from other new and existing investors including Aberdeen World Healthcare Fund, ADAR1 Capital Management, Balyasny Asset Management, Cormorant Asset Management, Frazier Life Sciences, RA Capital Management, RTW Investments, Sirenia Capital Management, Wellington Management, and Woodline Partners, Zai Lab said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4548","BK4531","BK4526","BK4139","BK4588","ZLAB","SCHY","BK4585","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677915489","title":"Zai Lab announces $250M private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2677915489","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677915489?lang=en_us&edition=fundamental","pubTime":"2026-10-23 09:05","pubTimestamp":1792717516,"startTime":"0","endTime":"0","summary":"Zai Lab (ZLAB) Limited announced that it has entered into a securities purchase agreement for the sale of 11,340,000 American Depositary Shares, ea...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zai-lab-announces-250m-private-placement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zai-lab-announces-250m-private-placement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4548","BK4526","BK4585","BK4588","ZLAB","BK4139","LU2488822045.USD","BK4531"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zailaboratory.com","stockEarnings":[{"period":"1week","weight":0.1545},{"period":"1month","weight":0.0067},{"period":"3month","weight":0.0926},{"period":"6month","weight":0.3699},{"period":"1year","weight":0.1006},{"period":"ytd","weight":0.4444}],"compareEarnings":[{"period":"1week","weight":-0.027},{"period":"1month","weight":-0.0539},{"period":"3month","weight":-0.0491},{"period":"6month","weight":-0.0032},{"period":"1year","weight":0.0969},{"period":"ytd","weight":0.0783}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.085823},{"month":2,"riseRate":0.555556,"avgChangeRate":0.030708},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.076257},{"month":4,"riseRate":0.444444,"avgChangeRate":0.02394},{"month":5,"riseRate":0.444444,"avgChangeRate":0.004882},{"month":6,"riseRate":0.555556,"avgChangeRate":0.07528},{"month":7,"riseRate":0.444444,"avgChangeRate":0.000111},{"month":8,"riseRate":0.666667,"avgChangeRate":0.044305},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.045569},{"month":10,"riseRate":0.4,"avgChangeRate":-0.058929},{"month":11,"riseRate":0.6,"avgChangeRate":0.106729},{"month":12,"riseRate":0.444444,"avgChangeRate":-0.029495}],"exchange":"NASDAQ","name":"Zai Lab Ltd","nameEN":"Zai Lab Ltd","securityTypeName":"DR","adrRate":"1:10"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zai Lab Ltd(ZLAB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Zai Lab Ltd(ZLAB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Zai Lab Ltd,ZLAB,Zai Lab Ltd股票,Zai Lab Ltd股票老虎,Zai Lab Ltd股票老虎国际,Zai Lab Ltd行情,Zai Lab Ltd股票行情,Zai Lab Ltd股价,Zai Lab Ltd股市,Zai Lab Ltd股票价格,Zai Lab Ltd股票交易,Zai Lab Ltd股票购买,Zai Lab Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zai Lab Ltd(ZLAB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Zai Lab Ltd(ZLAB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}